KARAMBIOSCIENCE
EST. 2026
EVIDENCE / 02
Karam/Resources/Commercial research source register
Resources / Commercial source register

A source trail.
Not borrowed authority.

59 source references underpin the commercial map. A listing, policy, rate card and research paper are different kinds of evidence. None implies a Karam partnership.

AI-generated cellular concept illustration; not experimental data
Concept illustration · not experimental data

Sources, dates and access limits.

The public pages adapt Karam’s Revenue, Funding and IP Map, 15 October 2026. This register preserves its 59 references. Reopened pages are identified below; the others remain dated source-map references. Prices, eligibility, deadlines and licensing terms require direct confirmation before action. Older policy guidance and rate cards are not presented as new 2026 scientific discoveries.

S22 / Commercial source

TEDCO Seed Funds ↗

Reference retained from the 15 October 2026 source map; not independently re-verified in this build.

S25 / Commercial source

VIPC funding for startups ↗

Source page reopened during this build; full terms and source claims were not independently audited.

S26 / Commercial source

NCBiotech: company funding ↗

Source page reopened during this build; full terms and source claims were not independently audited.

S32 / Commercial source

age1 fund FAQ ↗

Source page reopened during this build; full terms and source claims were not independently audited.

S33 / Commercial source

Hevolution: investments ↗

Reference retained from the 15 October 2026 source map; not independently re-verified in this build.

S34 / Commercial source

Kizoo ↗

Reference retained from the 15 October 2026 source map; not independently re-verified in this build.

S36 / Commercial source

VitaDAO research funding ↗

Reference retained from the 15 October 2026 source map; not independently re-verified in this build.

S38 / Commercial source

Hevolution: grants ↗

Reference retained from the 15 October 2026 source map; not independently re-verified in this build.

S52 / Commercial source

USPTO: managing a patent ↗

Reference retained from the 15 October 2026 source map; not independently re-verified in this build.

S56 / Commercial source

AWS Activate credits ↗

Reference retained from the 15 October 2026 source map; not independently re-verified in this build.

S57 / Commercial source

Google for Startups Cloud ↗

Reference retained from the 15 October 2026 source map; not independently re-verified in this build.

S59 / Commercial source

NIH: Bayh-Dole regulations ↗

Reference retained from the 15 October 2026 source map; not independently re-verified in this build.